Compare Neurocrine Biosciences Inc (NBIX) vs Direxion Daily S&P 500 Bull 3X Shares (SPXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Direxion Daily S&P 500 Bull 3X Shares — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Direxion Daily S&P 500 Bull 3X Shares trades at $270.48. The key difference: Neurocrine Biosciences Inc is trading nearer its 52-week high, Direxion Daily S&P 500 Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| NBIX | SPXL | |
|---|---|---|
Market Cap | $17.40B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $180.55 | $288.04 |
52-Week Low | $123.10 | $170.20 |
Enterprise Value | $16.49B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Direxion Daily S&P 500 Bull 3X Shares
SPXL aims for 300% of the S&P 500's daily performance. It uses swaps and futures to provide 3x leverage, making it a high-risk tool for short-term traders. Due to daily resets, it is prone to volatility decay and is not intended for long-term holding.
Read more on SPXL →
